-
Immunotherapy Approvals in 2015
In 2015, the FDA approved more immunotherapies than in any prior year.
-
First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval
Daratumumab (Darzalex®) is the first approved immunotherapy that targets CD38—a protein found in most multiple myeloma cells.
-
CRI Awards $29.3 Million to Fund Immunotherapies for All Kinds of Cancer
CRI committed new funds to accelerate research and clinical development.
-
CRI Member to Chair Immuno-Oncology 360 Conference
Dr. Axel Hoos, a member of the CRI Scientific Advisory Council, will chair and be the keynote…
-
CRI Scientists Honored With Five AACR Awards
Carl June, Elizabeth Jaffee, James Allison, David Baltimore, and Owen Witte pick up prestigious cancer awards.
-
CRI’s Impact on Colorectal Cancer Immunotherapy
CRI scientists have contributed significantly to the immunological understanding and treatment of colorectal cancer.
-
Immune Checkpoint Inhibitors: What’s Next?
What’s ahead beyond CTLA-4 and PD-1?
-
World Cancer Day: The Many Languages of Cure
From Bengali to Ukrainian, our scientists have one goal: to find a cure for all cancers within…
-
What’s in a Name?
Cancer immunotherapies can have some mind-boggling names. But there’s a reason for it all.
